Model-based optimization of combination protocols for irradiation-insensitive cancers

Area of Science:

• Oncology
• Radiation Oncology
• Computational Biology

Background:

• Cancer cells with wild-type p53 can develop resistance to radiation therapy due to alterations in the p53 regulatory network, such as downregulated PTEN or overexpressed Wip1.
• Radiation monotherapy may be ineffective against these resistant cancer types.

Purpose of the Study:

• To identify optimal combination protocols of targeted therapy and radiation for treating cancers resistant to radiation monotherapy.
• To investigate the impact of timing and Mdm2 inhibitor dosage in combination therapy using a computational model.

Main Methods:

• Utilized a stochastic computational model of the p53 regulatory network to simulate cell apoptosis.
• Evaluated combination protocols with varying irradiation intervals (12, 18, 24, 36 hours) and Mdm2 inhibitor delivery schedules.
• Incorporated assumptions of higher inhibitor uptake and irradiation dose in cancer cells compared to neighboring normal cells.

Main Results:

• The timing of Mdm2 inhibitor administration relative to irradiation significantly affects apoptotic fractions in both normal and cancer cells.
• Protocols with irradiation repeated every 24 or 36 hours, combined with two Mdm2 inhibitor doses per cycle, were most effective.
• These optimized protocols achieved >95% cancer cell apoptosis while sparing <10% of normal cells.

Conclusions:

• Combination therapy, specifically timed Mdm2 inhibition with fractionated radiation, can overcome radiation resistance in p53 wild-type cancers.
• The computational model successfully identified treatment strategies that maximize cancer cell death and minimize toxicity to surrounding normal tissues.
• These findings support the development of novel therapeutic strategies for radioresistant cancers.